文献速递心脑血管急症重症综合管理与镇静镇痛

院外心脏骤停后目标温度管理48小时与24小时对神经功能结局的影响:一项随机临床试验

Targeted Temperature Management for 48 vs 24 Hours and Neurologic Outcome After Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2017-01-01
一句话结论院外心脏骤停昏迷患者,33°C目标温度管理48小时对比24小时未显著改善6个月神经功能结局,但不良事件更多、ICU停留更长。

该国际多中心随机优效性试验纳入355例院外心脏骤停后昏迷成人患者,随机接受33±1°C目标温度管理48小时(n=176)或24小时(n=179),随后以0.5°C/h复温至37°C。主要终点6个月神经功能良好(CPC 1或2)在48小时组为69%(120/175),24小时组为64%(112/176),差异4.9%(95%CI -5%至14.8%),无统计学显著差异。6个月死亡率48小时组27% vs 24小时组34%,差异-6.5%(95%CI -16.1%至3.1%),无显著差异。48小时组不良事件更常见(97% vs 91%),ICU中位停留时间更长(151 vs 117小时)。

要点

  • 院外心脏骤停昏迷患者,33°C目标温度管理48小时对比24小时,6个月神经功能良好率69% vs 64%,差异4.9%(95%CI -5%至14.8%),未达统计学显著。
  • 6个月死亡率48小时组27% vs 24小时组34%,差异-6.5%(95%CI -16.1%至3.1%),无显著差异;至死亡时间HR 0.79(95%CI 0.54-1.15),无显著差异。
  • 48小时组不良事件发生率97% vs 24小时组91%,差异5.6%(95%CI 0.6%-10.6%),48小时组更高。
  • 48小时组ICU中位停留时间151小时 vs 24小时组117小时(P<.001),住院时间11 vs 12天(P=.50)无显著差异。
  • 作者结论:48小时33°C目标温度管理未显著改善6个月神经功能结局,但研究把握度有限,可能需进一步研究。

适用人群与场景

  • 纳入:成人、院外心脏骤停后昏迷患者,来自6个欧洲国家10所大学医院的10个ICU,2013年2月16日至2016年6月1日入组。

诊断标准与关键阈值

  • 神经功能结局采用大脑功能分类(CPC)评分,CPC 1或2定义为6个月神经功能良好。

处置流程与药物剂量

  • 目标温度管理:33±1°C,48小时组持续48小时,24小时组持续24小时。
  • 复温:目标温度管理结束后以0.5°C/h逐渐复温至37°C。

研究设计与关键结果

  • 研究类型:国际、研究者发起、结局评估者盲法、平行、实用性、多中心、随机临床优效性试验;10个ICU、10所大学医院、6个欧洲国家;355例随机(平均年龄60岁,295例[83%]男性),351例(99%)完成试验。
  • 主要终点:6个月神经功能良好(CPC 1或2)48小时组69%(120/175) vs 24小时组64%(112/176),差异4.9%(95%CI -5%至14.8%),相对风险1.08(95%CI 0.93-1.25),P=.33。
  • 6个月死亡率:48小时组27%(48/175) vs 24小时组34%(60/177),差异-6.5%(95%CI -16.1%至3.1%),相对风险0.81(95%CI 0.59-1.11),P=.19。
  • 至死亡时间:48小时组 vs 24小时组风险比0.79(95%CI 0.54-1.15),P=.22,无显著差异。
  • 不良事件:48小时组97% vs 24小时组91%,差异5.6%(95%CI 0.6%-10.6%),相对风险1.06(95%CI 1.01-1.12),P=.04。
  • ICU中位停留时间:48小时组151小时 vs 24小时组117小时,P<.001;住院时间:48小时组11天 vs 24小时组12天,P=.50。

证据类型、等级与局限

  • 证据类型:随机临床优效性试验(多中心)。
  • 局限:作者指出研究把握度可能有限,不足以检测临床重要差异,可能需进一步研究。

对床旁实践的改变

  • 对于院外心脏骤停后昏迷的ICU患者,33°C目标温度管理48小时对比24小时未显著改善6个月神经功能结局,但48小时组不良事件更常见(97% vs 91%)、ICU停留时间更长(中位151 vs 117小时)。
  • 作者结论:48小时目标温度管理未显著改善6个月神经功能结局,但研究把握度可能有限,可能需进一步研究。

指南或共识出处

  • 临床试验注册号:NCT01689077。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: International resuscitation guidelines recommend targeted temperature management (TTM) at 33°C to 36°C in unconscious patients with out-of-hospital cardiac arrest for at least 24 hours, but the optimal duration of TTM is uncertain.

OBJECTIVE: To determine whether TTM at 33°C for 48 hours results in better neurologic outcomes compared with currently recommended, standard, 24-hour TTM.

DESIGN, SETTING, AND PARTICIPANTS: This was an international, investigator-initiated, blinded-outcome-assessor, parallel, pragmatic, multicenter, randomized clinical superiority trial in 10 intensive care units (ICUs) at 10 university hospitals in 6 European countries. Three hundred fifty-five adult, unconscious patients with out-of-hospital cardiac arrest were enrolled from February 16, 2013, to June 1, 2016, with final follow-up on December 27, 2016.

INTERVENTIONS: Patients were randomized to TTM (33 ± 1°C) for 48 hours (n = 176) or 24 hours (n = 179), followed by gradual rewarming of 0.5°C per hour until reaching 37°C.

MAIN OUTCOMES AND MEASURES: The primary outcome was 6-month neurologic outcome, with a Cerebral Performance Categories (CPC) score of 1 or 2 used to define favorable outcome. Secondary outcomes included 6-month mortality, including time to death, the occurrence of adverse events, and intensive care unit resource use.

RESULTS: In 355 patients who were randomized (mean age, 60 years; 295 [83%] men), 351 (99%) completed the trial. Of these patients, 69% (120/175) in the 48-hour group had a favorable outcome at 6 months compared with 64% (112/176) in the 24-hour group (difference, 4.9%; 95% CI, -5% to 14.8%; relative risk [RR], 1.08; 95% CI, 0.93-1.25; P = .33). Six-month mortality was 27% (48/175) in the 48-hour group and 34% (60/177) in the 24-hour group (difference, -6.5%; 95% CI, -16.1% to 3.1%; RR, 0.81; 95% CI, 0.59-1.11; P = .19). There was no significant difference in the time to mortality between the 48-hour group and the 24-hour group (hazard ratio, 0.79; 95% CI, 0.54-1.15; P = .22). Adverse events were more common in the 48-hour group (97%) than in the 24-hour group (91%) (difference, 5.6%; 95% CI, 0.6%-10.6%; RR, 1.06; 95% CI, 1.01-1.12; P = .04). The median length of intensive care unit stay (151 vs 117 hours; P < .001), but not hospital stay (11 vs 12 days; P = .50), was longer in the 48-hour group than in the 24-hour group.

CONCLUSIONS AND RELEVANCE: In unconscious survivors from out-of-hospital cardiac arrest admitted to the ICU, targeted temperature management at 33°C for 48 hours did not significantly improve 6-month neurologic outcome compared with targeted temperature management at 33°C for 24 hours. However, the study may have had limited power to detect clinically important differences, and further research may be warranted.

TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01689077.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Kirkegaard H, Søreide E, de Haas I, et al. Targeted Temperature Management for 48 vs 24 Hours and Neurologic Outcome After Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA. 2017. PMID: 28742911. doi:10.1001/jama.2017.8978

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。